article thumbnail

9th Advanced GMP Workshop 2024 was organised by IPA

Express Pharma

It is encouraging to see that the Indian pharmaceutical sector is making significant strides towards becoming a global benchmark for quality through capability building, process improvements, talent development, digitalisation, and fostering a quality-first mindset.”

article thumbnail

The quest for quality continues

Express Pharma

The world is increasingly looking towards India, not just for our contributions to generic medicines, but for our growing leadership in advanced areas like biologics, medical devices, and digital health.” It’s not just a goal; it is the foundation of our global leadership, and the trust placed in us.

article thumbnail

IPA questions FAERS data interpretation in the Ohio State University study

Express Pharma

On the pricing of generics, IPA stated, While generics are priced lower than the corresponding brands, it is unfair and unacceptable to link quality with cost. It attributed Indias cost advantage to high-production capacity plants, process improvements, economies of scale, and backward integration in manufacturing.